Cardiovascular Disease Statistics in US 2025 | Facts

Cardiovascular Disease in America 2025

The cardiovascular health landscape in America continues to present significant challenges as we navigate through 2025. Despite decades of medical advancement and public health interventions, cardiovascular disease remains the nation’s leading cause of death, claiming more lives than all forms of cancer and chronic respiratory diseases combined. The burden of heart disease and stroke touches nearly every American family, with profound implications for individual health, healthcare systems, and the national economy.

What makes the current situation particularly concerning is the persistent rise in risk factors such as hypertension, diabetes, and obesity, even as treatment options have improved. The aging Baby Boomer generation, coupled with lifestyle changes and increasing rates of metabolic conditions, has created what many experts describe as a looming cardiovascular epidemic. Understanding the scope and scale of this challenge through accurate, government-verified statistics is essential for policymakers, healthcare professionals, and individuals seeking to make informed health decisions.

Key Cardiovascular Disease Stats & Facts in the US 2025

Data Source: Centers for Disease Control and Prevention (CDC) – National Center for Health Statistics, Multiple Cause of Death 2018-2023 Database; American Heart Association 2025 Heart Disease and Stroke Statistics Update; Heart Failure Society of America HF Stats 2025

The statistics paint a sobering picture of cardiovascular disease’s impact across the United States. With 919,032 deaths recorded in 2023, cardiovascular disease continues its reign as America’s number one killer, responsible for approximately one-third of all deaths nationwide. This translates to a staggering reality where one person dies every 34 seconds from some form of cardiovascular disease, whether it be coronary heart disease, stroke, heart failure, or other circulatory conditions.

The economic burden is equally overwhelming, with $417.9 billion spent between 2020 and 2021 on cardiovascular disease-related expenses. This massive figure encompasses direct healthcare costs including hospitalizations, medications, physician visits, and procedures, as well as indirect costs such as lost productivity due to premature death and disability. The financial strain affects not just individual families but the entire healthcare system and national economy. What makes these numbers particularly alarming is the prevalence of risk factors—nearly half of all American adults (48.1%) now live with hypertension, a primary driver of cardiovascular disease. The frequency of acute cardiovascular events remains disturbingly high, with heart attacks occurring every 40 seconds and strokes striking every 40 seconds as well, demonstrating the relentless nature of this health crisis.

Mortality Statistics for Cardiovascular Disease in the US 2025

Data Source: CDC National Center for Health Statistics, Multiple Cause of Death 2018-2023 Database; American Heart Association 2025 Heart Disease and Stroke Statistics Update

The mortality landscape reveals the devastating toll cardiovascular disease continues to exact on the American population. In 2023 alone, 919,032 individuals lost their lives to cardiovascular disease, making it unequivocally the leading cause of death and accounting for approximately one-third of all deaths in the United States. This represents not just a statistical figure but millions of families affected by premature loss and grief. Breaking down these deaths by specific cardiovascular conditions shows that coronary heart disease remains the primary killer, responsible for 371,506 deaths in 2022, which represents 39.5% of all cardiovascular-related deaths. This underscores the continued dominance of atherosclerotic disease despite advances in prevention and treatment strategies.

Stroke emerges as the second leading cardiovascular killer with 161,748 deaths in 2022, accounting for 17.6% of cardiovascular deaths. What’s particularly concerning is that hypertensive disease directly caused 128,674 deaths, representing 14.0% of CVD deaths, highlighting the critical importance of blood pressure management in preventing fatal outcomes. Heart failure contributed to 85,478 deaths or 9.3% of CVD deaths, though it’s important to note that heart failure was listed as a contributing cause in over 425,147 deaths, indicating its role as a complicating factor in many cardiovascular deaths. Perhaps most alarming is that approximately 1 out of every 6 cardiovascular deaths (16.7%) occurred in adults younger than 65 years old in 2023, with 153,172 premature deaths robbing society of productive years and devastating younger families. This statistic emphasizes that cardiovascular disease is not merely a condition of the elderly but affects Americans across all age groups.

Coronary Artery Disease Statistics in the US 2025

Data Source: CDC National Center for Health Statistics; American Heart Association 2025 Heart Disease and Stroke Statistics Update; Tsao CW, et al., Heart Disease and Stroke Statistics—2023 Update

Coronary artery disease continues to dominate the cardiovascular disease landscape in America, affecting approximately 5% of all adults aged 20 and older, which translates to roughly 1 in every 20 American adults living with this condition. Based on current population estimates, this means 12 to 13 million Americans are dealing with the challenges of coronary artery disease, whether through medication management, lifestyle modifications, or interventional procedures. The condition’s prevalence increases dramatically with age, making it one of the most significant health concerns for older Americans. As the leading cause of cardiovascular death, coronary artery disease claimed 371,506 lives in 2022, representing the largest single category of cardiovascular mortality and underscoring the critical need for both prevention and improved treatment strategies.

The acute manifestation of coronary artery disease—heart attacks—occurs with alarming frequency across the United States. Every 40 seconds, an American experiences a heart attack, creating a relentless cycle of emergency responses, hospitalizations, and long-term care needs. This frequency translates to approximately 805,000 heart attacks annually, a staggering number that strains emergency medical services and hospital systems nationwide. Of particular note is that 605,000 of these are first-time heart attacks, representing individuals who had no prior diagnosed coronary event, while 200,000 occur in people who have already survived a previous heart attack. This 75-25 split emphasizes both the importance of primary prevention and the ongoing risk faced by those with established disease. Perhaps most concerning is the phenomenon of silent heart attacks, which account for approximately 20% or 1 in 5 of all heart attacks. These events cause myocardial damage without the classic symptoms, meaning individuals may not seek treatment and remain unaware of their serious condition until subsequent complications arise.

Heart Failure Statistics in the US 2025

Data Source: Heart Failure Society of America HF Stats 2025; American Heart Association 2025 Statistics Update; CDC National Center for Health Statistics

Heart failure represents one of the most rapidly growing cardiovascular conditions in the United States, with 6.7 million Americans over age 20 currently living with this debilitating disease. This number is projected to rise to 8.7 million by 2030, reflecting both the aging population and the increasing survival rates from acute cardiovascular events that subsequently lead to chronic heart failure. The lifetime risk of developing heart failure has now reached 24%, meaning approximately 1 in every 4 Americans will develop heart failure at some point in their lifetime. This stark statistic emphasizes that heart failure is not a rare condition but rather a common endpoint for many cardiovascular disease processes, making it a public health priority that affects millions of families across all demographic groups.

The mortality burden of heart failure is substantial, with heart failure listed as a contributing cause in 425,147 deaths in 2022, accounting for 45% of all cardiovascular deaths. What’s particularly troubling is that heart failure mortality rates are now 3% higher than they were 25 years ago in 1999, reversing decades of progress and indicating that despite improved treatment options, population-level outcomes have deteriorated. The healthcare system faces immense pressure from heart failure, with more than 1 million hospitalizations annually primarily attributed to heart failure decompensation. The economic burden is equally staggering—direct medical costs reached $32 billion in 2020, while indirect costs from lost productivity added another $14 billion. Projections for 2050 vary widely depending on methodology, with estimates ranging from $142 billion to as high as $858 billion in total costs, reflecting uncertainty about future population health trends and healthcare inflation. Adding to these challenges is the concerning reality that fewer than 1 in 4 eligible patients with heart failure and reduced ejection fraction are receiving quadruple guideline-directed medical therapy, representing a massive gap between evidence-based care and actual clinical practice that could potentially save lives if addressed.

Stroke Statistics in the US 2025

Data Source: CDC National Center for Health Statistics; American Heart Association 2025 Heart Disease and Stroke Statistics; CDC Stroke Facts 2025

Stroke continues to exact a devastating toll on the American population, with 795,000 stroke events occurring annually across the United States. This staggering number means that every 40 seconds, someone in America experiences a stroke, whether ischemic, hemorrhagic, or transient ischemic attack. The relentless frequency of these events creates an enormous burden on emergency medical services, stroke centers, and rehabilitation facilities nationwide. The mortality associated with stroke is equally sobering—every 3 minutes and 14 seconds, an American dies from stroke, resulting in 161,748 stroke deaths in the most recent data from 2022-2023. Stroke accounts for 17.5% of all cardiovascular disease deaths, or approximately 1 in every 6 cardiovascular deaths, making it the second leading cause of cardiovascular mortality after coronary heart disease.

The prevalence of stroke survivors in the United States has grown to approximately 7.8 million adults living with the effects of previous stroke, many dealing with varying degrees of disability that affect their daily functioning, independence, and quality of life. The death rate from stroke in 2023 was 39.0 per 100,000 population, showing a slight improvement from the previous year but still representing thousands of preventable deaths. The economic burden is substantial, with stroke-related costs reaching $56.2 billion between 2019 and 2020, including healthcare services, medications, rehabilitation, and missed work days. The healthcare system manages over 2.6 million stroke-related medical encounters annually, with the majority occurring in emergency departments and requiring rapid intervention to minimize brain damage. What makes these statistics particularly tragic is that research indicates approximately 80% of strokes are preventable through proper management of risk factors such as hypertension, diabetes, atrial fibrillation, and lifestyle modifications. This means that with adequate prevention efforts, the majority of the 795,000 annual strokes could potentially be avoided, saving lives and reducing disability.

Hypertension Statistics in the US 2025

Data Source: CDC National Center for Health Statistics, NHANES 2021-2023; CDC High Blood Pressure Facts 2025; American Heart Association 2025 Statistics

Hypertension has reached epidemic proportions in the United States, with 119.9 million American adults affected, representing 48.1% or nearly half of the adult population. This means that approximately 1 in 2 American adults has high blood pressure, making it one of the most prevalent chronic conditions in the country. When age-adjusted to account for population demographics, the prevalence stands at 44.5% for the total adult population, with significant gender differences—48.8% of men and 40.1% of women have hypertension when age-standardized. The prevalence increases dramatically with age, affecting 69.2% of adults aged 60 and older, compared to only 26.7% of adults aged 18-39. This age gradient reflects both the cumulative effects of lifestyle factors and age-related vascular changes that drive blood pressure upward over time.

Despite the high prevalence, awareness and control of hypertension remain woefully inadequate. Only 59.2% of adults with hypertension are aware they have the condition, meaning more than 4 in 10 people with high blood pressure don’t even know they have it, often earning hypertension the moniker “silent killer.” Among those who are aware of their diagnosis, only 51.2% are currently taking medication for blood pressure management, indicating significant gaps in treatment initiation or adherence. Most concerning is that only 22-25% of people with hypertension have their blood pressure under control, meaning approximately 3 out of 4 adults with hypertension (75-78%) have uncontrolled blood pressure, placing them at substantially elevated risk for heart attack, stroke, and other cardiovascular complications. The consequences of uncontrolled hypertension are severe—high blood pressure was listed as a primary or contributing cause in 691,095 deaths in 2023, contributing to nearly 75% of cardiovascular disease deaths in the United States. The economic burden is equally substantial, with hypertension costing the nation approximately $131 billion each year averaged over the period from 2003 to 2014, including healthcare costs and lost productivity.

Cardiovascular Disease by Race and Ethnicity in the US 2025

Data Source: CDC National Center for Health Statistics, Multiple Cause of Death 2018-2023; American Heart Association 2025 Statistics; CDC High Blood Pressure Facts

Cardiovascular disease disproportionately affects different racial and ethnic groups in the United States, with Non-Hispanic Black individuals experiencing the highest cardiovascular mortality rate at 22.6% of all deaths in their population attributed to cardiovascular disease. This represents a significantly elevated burden compared to other groups and reflects longstanding health disparities rooted in social determinants of health, access to care, and genetic factors. Non-Hispanic White individuals have the second-highest rate at 18.0%, followed closely by Asian Americans at 18.6% and Native Hawaiian and Pacific Islander populations at 18.3%. These rates are substantially higher than the overall national average of 17.4%, indicating that multiple racial and ethnic groups face elevated cardiovascular risk.

American Indian and Alaska Native populations show a cardiovascular mortality rate of 15.5%, while Hispanic populations have the lowest rate at 11.9% of deaths attributed to cardiovascular disease. However, it’s crucial to note that lower mortality rates don’t necessarily indicate better cardiovascular health, as these statistics may be influenced by differences in age distribution, data collection methods, and competing causes of death. The disparities become even more pronounced when examining specific risk factors like hypertension. Black adults have the highest prevalence of high blood pressure at 58%, meaning more than half of Black adults in America live with hypertension. This is substantially higher than White adults at 49%, Asian adults at 45%, and Hispanic adults at 39%. These disparities in hypertension prevalence directly contribute to higher rates of stroke, heart failure, and kidney disease in Black communities. The data reveals that cardiovascular disease is not equally distributed across American society, and addressing these racial and ethnic disparities must be a central focus of public health efforts, requiring targeted interventions that address the social, economic, and healthcare access barriers that drive these differences.

Economic Burden of Cardiovascular Disease in the US 2025

Data Source: American Heart Association Presidential Advisories 2024; CDC Chronic Disease Facts; HFSA HF Stats 2025; National Heart, Lung, and Blood Institute

The economic burden of cardiovascular disease represents one of the most significant financial challenges facing the American healthcare system and economy. Between 2020 and 2021, total cardiovascular disease costs reached $417.9 billion, encompassing the full spectrum of direct medical expenses and indirect productivity losses. This massive figure includes healthcare services such as hospitalizations, emergency department visits, outpatient care, medications, medical devices, and procedures, as well as the economic impact of premature mortality and disability that reduces workforce participation. Looking forward, projections paint an even more alarming picture—total cardiovascular disease and stroke costs are expected to triple to approximately $1.8 trillion by 2050, driven by population aging, increasing prevalence of risk factors, and healthcare inflation.

Breaking down the 2020 baseline more specifically, healthcare costs for cardiovascular risk factors (hypertension, diabetes, hypercholesterolemia) totaled $400 billion, projected to reach $1.344 trillion by 2050, representing a more than three-fold increase. Healthcare costs for established cardiovascular conditions (coronary heart disease, stroke, heart failure, atrial fibrillation) were $393 billion in 2020, projected to nearly quadruple to $1.490 billion by 2050. Productivity losses from cardiovascular disease morbidity and premature mortality amounted to $234 billion in 2020, expected to increase 54% to $361 billion by 2050. Specific conditions contribute substantially to this burden: heart failure alone accounted for $46 billion in costs in 2020 ($32 billion direct, $14 billion indirect), with projections ranging from $142 billion to as high as $858 billion by 2050 depending on prevention and treatment success. Stroke-related costs reached $56.2 billion between 2019-2020 and are projected to account for the largest absolute increase in costs among cardiovascular conditions. Hypertension costs the United States approximately $131 billion annually, averaged over 2003-2014 data. These escalating costs threaten the sustainability of healthcare financing and underscore the urgent need for effective prevention strategies that can bend the cost curve while improving population health outcomes.

Projected Cardiovascular Disease Trends in the US 2025-2050

Data Source: American Heart Association Presidential Advisory 2024; Journal of the American College of Cardiology Cardiovascular Projections Study; NHANES Projection Data

The future trajectory of cardiovascular disease in the United States presents a sobering picture of escalating prevalence across all major conditions and risk factors. From a baseline of 127.9 million adults with some form of cardiovascular disease, projections indicate this number will reach 145 million by 2030 and 184 million by 2050, representing more than 61% of the total adult population. This dramatic increase is driven by multiple converging factors: the aging of the Baby Boomer generation into their highest-risk years, increasing prevalence of metabolic risk factors, and improved survival from acute cardiovascular events that creates a larger population living with chronic cardiovascular conditions.

The risk factor trends are particularly alarming. Hypertension prevalence is projected to increase from 51.2% in 2020 to 61.0% by 2050, meaning approximately 3 in 5 American adults will have high blood pressure by mid-century. Diabetes prevalence is expected to spike dramatically from 16.3% to 26.8%, nearly doubling and affecting more than 1 in 4 adults. Obesity rates are projected to climb from 43.1% to 60.6%, affecting more than 3 in 5 adults and serving as a primary driver of hypertension, diabetes, and subsequent cardiovascular disease. Specific cardiovascular conditions will see substantial increases: ischemic heart disease prevalence is projected to rise from 21.9 million in 2025 to 28.7 million by 2050, a 31% increase that represents 6.8 million more Americans living with coronary artery disease. Heart failure is expected to increase 33% from 9.7 million to 12.9 million, myocardial infarction 30% from 12.3 million to 16.0 million, and stroke 34% from 10.8 million to 14.5 million. These projections assume continuation of current trends without major prevention breakthroughs or policy changes, emphasizing the critical window of opportunity for intervention over the next several years to alter this trajectory.

The cardiovascular disease landscape in America stands at a critical juncture as we progress through 2025 and look toward the coming decades. While the statistics reveal a daunting picture of escalating prevalence, mortality, and economic burden, they also illuminate clear pathways for meaningful intervention and improvement. The American Heart Association’s modeling demonstrates that achieving even modest improvements in risk factor prevalence and control could yield extraordinary results—reducing risk factors by 10% and improving control rates by 20% could prevent 1.2 million cardiovascular events and save 240,000 lives annually by 2050. More aggressive interventions, particularly focusing on obesity reduction and doubling risk factor control rates, could prevent 2.3 million events and save over 450,000 lives each year. These projections prove that the future is not predetermined, and that strategic investments in prevention, early detection, and treatment optimization can fundamentally alter the trajectory of cardiovascular disease in America.

The path forward requires a multi-faceted approach that addresses cardiovascular health at individual, community, healthcare system, and policy levels. Critical priorities include improving hypertension awareness and control, given that three-quarters of those with high blood pressure remain uncontrolled; closing the massive treatment gap in heart failure where fewer than one in four eligible patients receive optimal therapy; addressing the stark racial and ethnic disparities that see Black Americans experiencing disproportionately higher rates of hypertension, stroke, and heart failure mortality; and implementing cost-effective population health strategies that can prevent the projected tripling of cardiovascular costs to 1.8 trillion dollars by 2050. The advancement of precision medicine, digital health technologies for remote monitoring and medication adherence, community-based prevention programs, and policies that address social determinants of health all offer promising tools for bending the curve on cardiovascular disease. Success will require sustained commitment from policymakers, healthcare systems, public health agencies, researchers, and individuals to prioritize cardiovascular health and implement evidence-based strategies that can transform these projections from dire warnings into preventable outcomes.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE